Olanzapine decreases cannabinoid CB1 receptors in the hypothalamus and brainstem, possibly through muscarinic M3 receptor antagonism

Authors

Katrina Weston-Green, University of WollongongFollow
Xu-Feng Huang, University of WollongongFollow
K Kang, Ninth Hospital of Chongqing, China
Chao Deng, University of WollongongFollow

RIS ID

36764

Publication Details

Weston-Green, K., Huang, X. F., Kang, K. & Deng, C. (2010). Olanzapine decreases cannabinoid CB1 receptors in the hypothalamus and brainstem, possibly through muscarinic M3 receptor antagonism. International Journal of Neuropsychopharmacology, 13 (Supplement S1), 111-112.

Abstract

Abstract from the XXVII CINP Congress, 6-10 June 2010, Hong Kong